Pathology

Esophageal Cancer in Relative Increases Barrett’s Risk
Barrett's esophagus refers to an abnormal change (metaplasia) in the cells of the lower portion of the esophagus. It is characterized by the replacement of the normal stratified squamous epithelium lining of the esophagus by simple columnar epithelium with goblet cells. More...09 Nov 2017

New Method Helps Rule Out Heart Valve Infection
If a blood sample shows the presence of what is known as alpha-streptococci, there is a risk that the person suffers from infective endocarditis, a heart valve infection and it is an inflammation of the inner tissues of the heart, the endocardium, usually of the valves. More...08 Nov 2017

Blood Test Can Effectively Rule Out Breast Cancer
Breast density is associated with reduced imaging resolution in the detection of breast cancer. Breast density is a radiologic phenomenon that is not discernable by palpation; it is a radiologist’s assessment. Imaging rays permeate dense breast tissue in a more opaque manner, thereby reducing image resolution. More...07 Nov 2017

Noninvasive Test Detects Bladder Cancer
In Europe, bladder cancer represents the fourth most common cancer in men and the 15th most common cancer in women, with 151,000 people diagnosed with the condition in 2012. In order to make a bladder cancer diagnosis, experts currently recommend cystoscopy for all patients with hematuria, in conjunction with computed tomography (CT) urography (in selected high-risk patients) or renal and bladder ultrasound. More...07 Nov 2017

CK-MB Assay Used to Diagnose Acute Myocardial Infarction
Creatine Kinase (CK) is an enzyme found in high amounts in muscle tissue due to its role in muscle contraction. CK-MB is found mainly in cardiac muscle, where it comprises 15%-40% of the total CK activity, with the remainder being CK-MM. More...07 Nov 2017

Single-Cell Diagnostics Advocated for Breast Cancer Subtyping
In an opinion article based their analysis of studies, two medical researchers argue that women diagnosed with breast cancer (BC) would likely benefit from treatment based also on identifying the molecular subtype of different cells within their tumors, in addition to current molecular and histopathology testing of collections of tumor cells. More...06 Nov 2017

Urine-Based Markers for Bladder Cancer Reviewed
The advances in understanding bladder cancer at the molecular and genetic level have led to the identification of detectable and measurable alterations associated with the disease. Given the ease of obtaining voided urine and its direct contact with potentially malignant urothelium, numerous urine-based tumor marker tests have been generated. More...01 Nov 2017
In Other News
Genetic Testing Recommended for Children at Risk for Retinoblastoma
Risk for Colorectal Cancer Linked to Polyps and Adenomas
Liquid Biopsy for Retinoblastoma Discovered
Metabolomics Analysis Applied to Investigate MPS
New 3D App Provides More Accurate Cancer Diagnosis
Liquid Biopsy Test Outperforms Prostate Cancer PCA3 Test
Pre-Op Test Can Detect Some Pancreatic Cancers
Genetic Test Discovered for Predicting Cancer Recurrence
HPV Testing Detects More Precancerous Lesions
Immunocompromised Patients at Risk for Blastomycosis
Urinary Tract Biopsy Correlates Urothelial Carcinoma Diagnosis
Genetic Cause of Peritoneal Mesothelioma Discovered
Blood Test Predicts Treatments for Lung Cancer Patients
Protein Network Mutations Impact Revealed in Bowel Cancer
Cholesterol Diagnosis Related to Breast Cancer Risk
IBS Colon Reacts Differently to Bacteria
Combination Liquid Biopsy Diagnoses Early Cancer
Early Stage Melanoma Identified by Simple Blood Test
Handheld Mass Spectrometer Identifies Cancer Tissue in Seconds
Epstein-Barr Virus Increases Risk of MS
Tumor Marker Tests Overused in Primary and Secondary Care
Blood Test Predicts Prostate Tumor Resistance
Liquid Biopsy Panel Yields Complete Molecular Profile
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.